Antiproliferative and Apoptotic Effects of Cardamonin against Hepatocellular Carcinoma HepG2 Cells
Liver cancer is the sixth most common cancer in terms of incidence and the fourth in terms of mortality. Hepatocellular carcinoma (HCC) represents almost 90% of primary liver cancer and has become a major health problem globally. Cardamonin (CADMN) is a natural bioactive chalcone found in several ed...
Main Authors: | Nassrin A. Badroon, Nazia Abdul Majid, Mohammed A. Alshawsh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/6/1757 |
Similar Items
-
Cardamonin Exerts Antitumor Effect on Human Hepatocellular Carcinoma Xenografts in Athymic Nude Mice through Inhibiting NF-κβ Pathway
by: Nassrin Badroon, et al.
Published: (2020-12-01) -
Antiproliferative Activity and Induction of Apoptosis in PC-3 Cells by the Chalcone Cardamonin from Campomanesia adamantium (Myrtaceae) in a Bioactivity-Guided Study
by: Aislan Cristina Rheder Fagundes Pascoal, et al.
Published: (2014-02-01) -
Taurine combined with SN50 inhibits the proliferation of human hepatocellular carcinoma cell line HepG2
by: LEI Qiao-li, RAO Qi-bin, LIN Ze-wen
Published: (2020-03-01) -
Farnesiferol C Exerts Antiproliferative Effects on Hepatocellular Carcinoma HepG2 Cells by Instigating ROS-Dependent Apoptotic Pathway
by: Ahmed Alafnan, et al.
Published: (2022-08-01) -
Dehydrocostuslactone inhibits proliferation and promotes apoptosis of human hepatocellular carcinoma cell line HepG2
by: MIAO Jia-wei, CHEN Jie, DENG Xue-song, XIONG Shu, LI Guo-li, MA Qiang
Published: (2020-10-01)